Table 3.
Correlation between the reduction in the duration of hypoglycemia or in HbA1c level at 12 months after the switch to SAP therapy and other parameters
| Parameter | Reduction in duration of hypoglycemia | Reduction in HbA1c level |
|---|---|---|
| Age |
P = 0.44 r = 0.19 |
P < 0.05 r = − 0.49 |
| Baseline HbA1c level |
P = 0.19 r = 0.32 |
P = 0.09 r = 0.41 |
| Frequency of self-monitoring of blood glucose (SMBG) |
P = 0.20 r = − 0.31 |
P = 0.35 r = − 0.23 |
| Sensor usage |
P = 0.69 r = − 0.10 |
P = 0.53 r = − 0.16 |
| Frequency of hypoglycemic alarms |
P = 0.68 r = − 0.11 |
P = 0.43 r = 0.20 |
| Frequency of hyperglycemic alarms |
P = 0.91 r = − 0.03 |
P = 0.05 r = 0.47 |
| Bolus frequency |
P = 0.27 r = − 0.28 |
P = 0.46 r = 0.19 |
| Frequency of correction bolus |
P = 0.38 r = − 0.22 |
P = 0.53 r = − 0.16 |